Add Row
Add Element
cropper
update

Provider Impact

update
Add Element
  • Home
  • Categories
    • Medicare + RTM
    • Pharmacy Insights
    • Provider Spotlights
    • HR & Staff Benefits
  • Featured Business Profiles
June 23.2025
2 Minutes Read

Carilion Clinic Leads the Charge: 13 New Hires Slashing HAIs in Virginia

Carilion Clinic infection control improvements featured in Becker's Hospital Review.

Carilion Clinic's Bold Move: A Commitment to Infection Control

In a significant investment in health security, the Carilion Clinic in Roanoke, Virginia, has made substantial improvements in healthcare-associated infection (HAI) rates. By ramping up its infection prevention and control team from 11 to 24 full-time staff members, the eight-hospital system has seen impressive results. Reported data shows that catheter-associated urinary tract infections have dropped by 57%, Clostridioides difficile infections have decreased by 52%, colon surgical site infections are down by 26%, and central line-associated bloodstream infections have fallen by 16% since this increase in staffing.

Understanding the Financial ROI of Infection Control Staffing

Maimuna Jatta, RN, MSN, Director of Infection Prevention and Control at Carilion Clinic, emphasizes the importance of presenting a solid financial argument when advocating for more staff. Jatta suggests that infection prevention (IP) leaders collaborate closely with finance personnel to delve into the cost implications of HAI events. This involves projecting potential savings through reduced infections and creating a data-driven case for strengthening IP staffing and strategies. This approach not only defends healthcare expenditures but also aligns with broader goals of improving patient safety and health outcomes.

Lessons from Carilion Clinic: Potential Pluses for Independent Healthcare Providers

What Carilion Clinic has accomplished serves as a key learning opportunity for independent physicians and healthcare providers. As the industry grapples with increasing demands for patient safety and quality care, similar strategies can be mirrored across settings. By understanding the value of enhanced staffing in infection control, individual practices can open discussions about optimizing practice efficiency solutions and improving clinic profitability while contributing positively to community health.

The Human Element: Impacting Patient Engagement and Care Quality

The establishment of a dedicated infection control team enhances not only compliance with healthcare regulations but also fosters an environment where patient engagement flourishes. With effective monitoring and management of HAIs, clinicians can assure patients that their health and safety are prioritized. This ultimately builds trust, strengthens doctor-patient relationships, and encourages patients to be active participants in their healthcare journeys.

Future Opportunities: A Pathway Towards Improved Health Outcomes

As Carilion Clinic continues to innovate its approach to infection control, the potential for future advancements grows. The expansion of infection prevention teams may lead to broader applications of technology to support clinical practices, such as voice AI agents for improved communication and remote therapeutic monitoring (RTM) programs. Employing these innovations enhances healthcare compliance and can drive healthcare automation forward, ensuring that both patients and providers benefit from these cutting-edge solutions.

Call to Action: Take Steps Toward Better Patient Care

As healthcare providers navigate the complexities of patient care, let Carilion Clinic's success story serve as a driving force for change. By investing in infection prevention and employing innovative strategies, healthcare professionals can ensure a safer environment for their patients and improve their practice operations. Explore the potential benefits of implementing similar approaches in your healthcare practice and consider how collaborative efforts can lead to enhanced health outcomes.

Provider Spotlights

4 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
09.22.2025

Promising Quadruplet Therapy Transformation for Older Patients with Transplant-Ineligible Myeloma

Update Quadruplet Regimen Offers Hope for Older Patients with Multiple Myeloma In the realm of hematologic cancers, newly diagnosed multiple myeloma (NDMM) poses significant challenges, particularly for older patients who often face compounded health issues. However, recent findings from a phase II clinical trial presented at the International Myeloma Society annual meeting reveal a promising treatment regimen—a quadruplet therapy including daratumumab (Darzalex), lenalidomide (Revlimid), ixazomib (Ninlaro), and dexamethasone (D-RId) that has shown formidable efficacy in an older, transplant-ineligible patient demographic. Encouraging Results from the Clinical Trial Dr. Andrew J. Yee from Massachusetts General Hospital reported that this tailored approach resulted in an overall response rate of 92.4% among the 79 evaluable patients. Specifically, a very good partial response was observed in 69.6% of participants, whereas a complete response was noted in 22.8%. These results offer a beacon of hope, especially considering that 41.8% of patients in the trial were identified as frail, complicating their treatment options. Understanding the Tailored Approach The rationale underlying the modification of the D-RId regimen is crucial: traditional treatments often focused on younger patients may not suit their older counterparts, who typically present with varying degrees of frailty. The trial addressed this by reducing the lenalidomide dosage from the standard 25 mg to a more tolerable 15 mg and substituting bortezomib with the oral proteasome inhibitor ixazomib. These adaptations are vital in improving overall tolerability and reducing potential side effects such as peripheral neuropathy—a particularly significant consideration for older patients susceptible to falls. Significance of Forsaking a One-Size-Fits-All Approach Yee's insights challenge the prevailing notion that treatment protocols should apply universally regardless of patient demographics. With many existing trials aimed at younger, fitter populations, the need for customization becomes apparent. The community must pivot towards a more nuanced understanding of treatment efficacy across different age groups and health statuses. Promising Progression-Free Survival Rates After completing 12 cycles of the D-RId therapy, the study showed remarkable 12-month progression-free survival (PFS) and overall survival rates at 92% and 93.6%, respectively. Breaking the data down further by patient frailty illustrates an essential pathway in understanding treatment effectiveness. For non-frail patients under 80, the PFS rates were 95.4%, while frail patients in the same age bracket experienced an impressive 95.0%. But stark disparities arise for patients over 80, illustrating the reality of managing cancer in older populations. Looking Ahead: The Future of Treatment for NDMM The current findings are not only crucial for immediate treatment options but also set the stage for future research. As healthcare continues to innovate and evolve, the integration of patient-specific strategies like this could drive further advancements in multiple myeloma care. Moreover, the study encourages the medical community to explore alternative therapies and the potential for combining oral and intravenous treatments to better serve an aging population. Engagement with the Healthcare Community As these findings resonate through the healthcare landscape, physicians, nurse practitioners, and medical educators must engage with the latest clinical research updates and evidence-based practices. Staying informed about these advancements is crucial for optimizing disease management and improving patient outcomes in this vulnerable demographic. In conclusion, the results from this phase II trial not only showcase the efficacy of the modified carb regimen but also pave the way for a paradigm shift in how we approach treatment for an aging population battling multiple myeloma. As we strive for healthcare innovation, prioritizing patient-centered approaches tailored to individual needs will remain paramount.

09.21.2025

Unlocking the Surprising Benefits of GLP-1s for Psoriasis Patients

Update Exploring the Benefits of GLP-1 Medications for Psoriasis Patients A recent study has unveiled promising insights regarding the potential benefits of GLP-1 medications, such as Zepbound and Wegovy, for individuals living with psoriasis. This research, presented at the European Academy of Dermatology and Venereology on Sept. 18, highlights not only the established advantages of these drugs in weight management and glucose regulation but also their unexpected positive impact on cardiovascular health and mental well-being. Beyond Weight Loss: The Holistic Impact of GLP-1s The allure of GLP-1 medications has primarily surrounded their effectiveness in aiding weight loss, which is particularly valuable for many individuals battling psoriasis—often associated with obesity. However, the recent study challenges healthcare professionals to reconsider these medications as multifaceted therapeutic options. Researchers compared health outcomes of over 3,000 patients using GLP-1s to another cohort of psoriasis patients utilizing alternative diabetes medications, alongside a wider sample of more than 110 million Americans without psoriasis. Notably, they identified the anti-inflammatory properties of GLP-1s as a critical factor that might contribute to their added benefits. Understanding the Mechanisms: Why GLP-1s Work Scientists speculate that the effectiveness of GLP-1 drugs among psoriasis patients lies in their dual action. First, these medications engage with the body’s inflammatory response—a key player in psoriasis flare-ups. Second, they appear to connect with brain regions linked to mood regulation and addiction, potentially offering psychiatric benefits. For many patients, managing psoriasis is not just a matter of physical symptoms, but also an emotional battle. The enhancement of mood and stress relief through these drugs might pave the way for a more holistic approach to treatment. An Emerging Conversation: GLP-1s and Patient Engagement As healthcare providers seek innovative treatment solutions, the excitement around GLP-1s invites independent physicians, nurse practitioners, and other providers to actively engage in discussing these options with their patients. Emphasizing the importance of a comprehensive treatment plan that looks beyond mere symptom management can significantly enhance patient satisfaction and outcomes. Notably, implementing telehealth systems and patient engagement tools can optimally facilitate these discussions, making medical advice more accessible and ensuring that patients feel motivated to participate fully in their treatment journeys. Addressing Barriers: Considerations for Providers Despite the exciting findings, barriers remain. For many healthcare providers, understanding reimbursement options and navigating insurance underpayments linked to new medication prescriptions and treatment plans are essential. Establishing connections with Medicare-backed services, alongside innovative healthcare compliance strategies, can increase practice efficiency. Additionally, integrating remote therapeutic monitoring (RTM) programs and adopting voice AI agents can streamline referral processes and improve overall patient experience. The Future of Psoriasis Treatment: Trends and Predictions As research progresses, the treatment of psoriasis may see revolutionary changes. Continued exploration of GLP-1 mechanisms could spark a wave of new therapeutic options that integrate both physical and mental health strategies. Physicians and healthcare providers should stay informed about emerging trends in healthcare automation as they relate to this field, which can combine with proactive financial planning, such as understanding FICA tax savings through employee health benefits programs, to enhance the sustainability and profitability of medical practices. Conclusion: The Call for Action in Psoriasis Treatment By embracing the benefits of GLP-1 medications, healthcare providers can provide a more robust treatment landscape for psoriasis patients. These drugs may not only address weight management and glucose control but also enhance cardiovascular and mental health. It’s vital for medical professionals to continue exploring these realms while optimizing resources and compliance strategies to adapt to the advancements in this promising field. Independent healthcare providers are encouraged to initiate conversations around GLP-1 treatments with their patients, keeping abreast of industry changes that impact patient care. Together, we can foster a healthier future for those affected by psoriasis, encouraging a shift towards comprehensive, patient-focused care.

09.21.2025

VCU Medical Center's New President Jim Willis: A Transformative Leader for Healthcare

Update Jim Willis Takes the Lead at VCU Medical Center In an exciting development for Richmond, Virginia, VCU Medical Center has officially appointed Jim Willis as its new president. Having served as the interim president since February, Willis is stepping into a role that consolidates his extensive experience in hospital leadership, spanning 35 years. Before becoming interim president, he held the position of Chief Operating Officer (COO) and, before that, he played a significant role in improving operational efficiencies in various capacities within the medical center. A Record of Accomplishments Since joining VCU Health in June 2022, Willis has implemented significant changes to enhance staff and patient experiences. His initiatives have included improving employee engagement scores and strengthening patient access to health services. Notably, he instituted weapons screening at 22 entry points, emphasizing safety and security—a pressing concern in today’s healthcare environment. Ensuring a Healthier Future for Employees and Patients Under Willis's leadership, VCU Medical Center is expected to focus on maximizing practice efficiency solutions and boosting employee health benefits. In a time when healthcare costs are rising, optimizing clinic workflows can greatly impact both practitioners and patients. With his background, Willis is poised to adopt new strategies such as practice automation and Medicare reimbursement reforms that promise to enhance the overall experience for both healthcare providers and patients. Transitioning into Leadership Willis’s transition from COO to president signals a commitment to continuity and strategic growth. Building upon the existing operational framework, he aims to leverage innovative tools like remote therapeutic monitoring (RTM) programs and patient engagement tools to ensure that medical decisions are data-driven and patient-focused. The integration of technology, such as voice AI agents for patient interactions, can also streamline communication and enhance service delivery within the medical center. The Importance of Employee Engagement The past few years have highlighted the critical role of healthcare employees' well-being in delivering quality patient care. Improved employee engagement has been a priority for Willis, aligning with findings from various studies that suggest happier staff create better outcomes for patients. The focus on nurturing a positive working environment can lead to higher retention rates and productivity, ultimately reducing costs associated with hiring and training new medical staff. Community Health and Patient Engagement With a vision that extends beyond the immediate needs of the hospital, Willis is also committed to fostering community health. By emphasizing accessible senior care solutions and aging in place initiatives, he places VCU Medical Center at the forefront of comprehensive patient care. The addition of telehealth revenue streams and digital front desk options underlines the commitment to innovate traditional healthcare practices and enhance patient engagement. A New Era of Governance in Healthcare As VCU Medical Center enters this new phase with Jim Willis at the helm, stakeholders are eager to see how his leadership will transform patient care dynamics. The paradigms of healthcare governance are evolving, and the focus on not just compliance, but also healthcare excellence, will define the success of medical institutions in an increasingly competitive landscape. Conclusion: Why This Matters For independent physicians and small practice owners, the appointment of leaders like Jim Willis is not just someone new at the top; it represents hope for better operational practices and revenue optimization strategies rooted in community health principles. Follow these changes closely, as they may influence broader trends that affect your practice in profound ways.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*